Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Kumar

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Transplantation and Cellular Therapy|August 15, 2023
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation RecipientsAnkit Mittal, Javier T Solera, Victor H Ferreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2026
RSV Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345Erick F Mayer, Ann R Falsey, Cameron R Wolfe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2019
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipientsDeepali Kumar, Peter Chin-Hong, Liise Kayler, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Tacrolimus Impairs Kupffer Cell Capacity to Control Bacteremia: Why Transplant Recipients Are Susceptible to InfectionCarsten Deppermann, Moritz Peiseler, Joel Zindel, et al.
The New England Journal of Medicine|June 15, 2007
Anidulafungin versus fluconazole for invasive candidiasisAnnette C Reboli, Coleman Rotstein, Peter G Pappas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2024
Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipientsMitsuaki Kawashima, Jin Ma, Ella Huszti, et al.
The Canadian Journal of Cardiology|March 25, 2023
The COVID-19 Pandemic and Adult Cardiac Transplantation: Impact, Interventions, and ImplicationsSharon Chih, Brian A Clarke, Martin Albert, et al.
The Journal of Infection|May 15, 2026
Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipientsMelinda M Hutton, Peter E Vink, Adrienne Kuxhausen, et al.
Transplantation and Cellular Therapy|August 1, 2022
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant RecipientsMuneyoshi Kimura, Victor H Ferreira, Sagar Kothari, et al.
The Journal of Rheumatology|February 3, 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Transplantation and Cellular Therapy|August 15, 2023
Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation RecipientsAnkit Mittal, Javier T Solera, Victor H Ferreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2026
RSV Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345Erick F Mayer, Ann R Falsey, Cameron R Wolfe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2019
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipientsDeepali Kumar, Peter Chin-Hong, Liise Kayler, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Tacrolimus Impairs Kupffer Cell Capacity to Control Bacteremia: Why Transplant Recipients Are Susceptible to InfectionCarsten Deppermann, Moritz Peiseler, Joel Zindel, et al.
The New England Journal of Medicine|June 15, 2007
Anidulafungin versus fluconazole for invasive candidiasisAnnette C Reboli, Coleman Rotstein, Peter G Pappas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2024
Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipientsMitsuaki Kawashima, Jin Ma, Ella Huszti, et al.
The Canadian Journal of Cardiology|March 25, 2023
The COVID-19 Pandemic and Adult Cardiac Transplantation: Impact, Interventions, and ImplicationsSharon Chih, Brian A Clarke, Martin Albert, et al.
The Journal of Infection|May 15, 2026
Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipientsMelinda M Hutton, Peter E Vink, Adrienne Kuxhausen, et al.
Transplantation and Cellular Therapy|August 1, 2022
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant RecipientsMuneyoshi Kimura, Victor H Ferreira, Sagar Kothari, et al.
The Journal of Rheumatology|February 3, 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Pageof 24